Lv11
10 积分 2024-09-23 加入
FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin
3小时前
已完结
FcRn: From Molecular Interactions to Regulation of IgG Pharmacokinetics and Functions
12天前
已完结
Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing
5个月前
已完结
GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations
5个月前
已完结
DPP-4 inhibitors: pharmacological differences and their clinical implications
6个月前
已完结
Dipeptidylpeptitase-4 Inhibitors (Gliptins)
6个月前
已完结
Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus
7个月前
已完结
User’s guide to mechanism of action and clinical use of GLP-1 receptor agonists
7个月前
已完结
Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
7个月前
已完结
Anti-Diabetic Drugs GLP-1 Agonists and DPP-4 Inhibitors may Represent Potential Therapeutic Approaches for COVID-19
7个月前
已完结
皖公网安备34019202002308
